# The Medicines (Control of Substances for Manufacture) Order 1971, Schedule 1


Column 1
Column 2
Substances appearing to the Ministers to be substances which, as described in article 3 of this order, are not themselves medicinal products but which are used as ingredients in the manufacture of medicinal products
Circumstances in which the order applies to the substances referred to in Column 1
1. Amphotericin B
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
2. Bacitracin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
3. Capreomycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
4. Colistin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
5. Erythromycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
6. Gentamicin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
7. Heparin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
8. Hyaluronidase
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
9. Kanamycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
10. Neomycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
11. Penicillin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
12. Polymyxin B
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
13. Preparations of the pituitary (posterior lobe)
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
14. Streptomycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
15. The lincomycins
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
16. The rifamycins
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
17. The tetracyclines
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
18. Vancomycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
19. Viomycin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals.
20. Oxytetracycline
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product which is to be administered to human beings or animals by means other than parenteral injection.
21. Tetracycline
Substances appearing to the Ministers to be substances which, as described in article 3 of this order, are not themselves medicinal products but which are used as ingredients in the manufacture of medicinal products
Circumstances in which the order applies to the substances referred to in Column 1
22. Dextrans
When manufactured, assembled, sold, supplied, imported or exported for use as ingredients of dextran injections for human or animal use.
23. Antigens
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
24. Antisera
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
25. Antitoxins
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
26. Chorionic gonadotrophin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
27. Corticotrophin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
28. Follicle-stimulating hormone
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
29. Insulin
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
30. Sera
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
31. Streptodornase
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
32. Streptokinase
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
33. Toxins
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
34. Vaccines
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use.
35. Preparations of blood
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human use.
36. Plasma
When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for administration to animals.
37. Any substances wholly or partly derived from animals not being substances specifically mentioned in any of the above paragraphs of this column.

---
Source: https://www.legislation.gov.uk/uksi/1971/1200/schedule/1 (the official version)
Page: https://openlegislation.uk/medicines-control-of-substances-for-manufacture-order-1971/schedule-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.